| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10908815 | Leukemia Research | 2014 | 5 Pages |
Abstract
Thus, TP53 mutations strongly correlated with poorer survival in higher risk MDS and AML treated with AZA.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Cecile Bally, Lionel Adès, Aline Renneville, Marie Sebert, Virginie Eclache, Claude Preudhomme, Marie-Joelle Mozziconacci, Hugues de The, Jacqueline Lehmann-Che, Pierre Fenaux,